Erythrodermic psoriasis precipitated by B‐cell chronic lymphocytic leukemia
- 20 February 2021
- journal article
- letter
- Published by Hindawi Limited in Dermatologic Therapy
- Vol. 34 (3), e14904
- https://doi.org/10.1111/dth.14904
Abstract
Click on the article title to read more.Keywords
This publication has 9 references indexed in Scilit:
- Erythrodermic psoriasis de novo versus skin lesions in chronic lymphocytic leukaemiaAdvances in Dermatology and Allergology, 2020
- Erythrodermic Psoriasis in a Man with Monoclonal B-cell LymphocytosisCureus, 2017
- Erythrodermic psoriasis: pathophysiology and current treatment perspectivesPsoriasis: Targets and Therapy, 2016
- Human B cells induce dendritic cell maturation and favour Th2 polarization by inducing OX-40 ligandNature Communications, 2014
- Anti-Tumor Necrosis Factor-α Therapy in the Management of Psoriasis and B-Chronic Lymphocytic LeukemiaCase Reports in Dermatology, 2011
- To B or not to B: B cells and the Th2-type immune response to helminthsTrends in Immunology, 2010
- Treatment of erythrodermic psoriasis with etanerceptBritish Journal of Dermatology, 2006
- The clinical significance of tumor necrosis factor-α plasma level in patients having chronic lymphocytic leukemiaBlood, 2002
- Production of tumor necrosis factor-alpha by B-cell chronic lymphocytic leukemia cells: a possible regulatory role of TNF in the progression of the diseaseBlood, 1990